Eculizumab: A Guide to its Use in Paroxysmal Nocturnal Hemoglobinuria

被引：8
|
作者：
Keating, Gillian M. [1 ]
Lyseng-Williamson, Katherine A. [1 ]
McKeage, Kate [1 ]
机构：
[1] Adis Int Ltd, Auckland 10, New Zealand
来源：
BIODRUGS | 2012年 / 26卷 / 02期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB;
D O I：
10.2165/11208420-000000000-00000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The targeted terminal complement inhibitor eculizumab (Soliris (R)) reduces intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH), as well as stabilizing hemoglobin levels, improving fatigue and health-related quality of life, and reducing the requirement for packed red cell transfusions. Eculizumab is generally well tolerated in patients with PNH, although the risk of Neisseria meningitidis infection is increased with eculizumab, meaning that patients must be vaccinated.
引用
收藏
页码：125 / 130
页数：6
相关论文
共 50 条
  • [41] Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria
    Seregina, E. A.
    Tsvetaeva, N. V.
    Nikulina, O. F.
    Zapariy, A. P.
    Erasov, A. V.
    Gribkova, I. V.
    Orel, E. B.
    Ataullakhanov, F. I.
    Balandina, A. N.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (02) : 144 - 150
  • [42] Ham Test For Therapeutic Monitoring Of Eculizumab In Paroxysmal Nocturnal Hemoglobinuria
    Arcavi, Miriam
    Ceballo, Fernanda
    Brodsky, Andres L.
    Halperin, Nora Silvia
    Cantenys, Norma
    Colin, Laura Beatriz
    Malusardi, Cecilia
    Lazarowski, Alberto
    [J]. BLOOD, 2013, 122 (21)
  • [43] Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond
    Risitano, A. M.
    Scalia, G.
    Marando, L.
    Ranaldi, D.
    Ricci, P.
    Selleri, C.
    Rodeghiero, F.
    Zanella, A.
    Iori, A. P.
    Luzzafto, L.
    Del Vecchio, L.
    Rotoli, B.
    [J]. CYTOMETRY PART A, 2008, 73A (01) : 53 - 54
  • [44] Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond
    Risitano, A. M.
    Hill, A.
    Ricci, F.
    Selleri, C.
    Marando, L.
    Gianfaldoni, G.
    Marinelli, F.
    Milano, F.
    Amendola, A.
    Boschetti, C.
    Di Bona, E.
    Barbano, E.
    D'Amico, P.
    Rodeghierc, F.
    Zanella, A.
    Iori, A. P.
    Notaro, R.
    Rother, R. P.
    Kroon, H. A.
    Hillmen, P.
    Luzzatto, L.
    Rotoli, B.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 89 - 90
  • [45] Paroxysmal Nocturnal Hemoglobinuria -- Hemolysis before and after Eculizumab.
    Risitano, Antonio M.
    Notaro, Rosario
    Luzzatto, Lucio
    Hill, Anita
    Kelly, Richard
    Hillmen, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2270 - 2273
  • [46] Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan
    Ooe, Yokiko
    Nagai, Tomoko
    [J]. SPRINGERPLUS, 2014, 3 : 1 - 5
  • [47] Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
    Ilic, Jovanka
    Pujic, Borislava
    Jakovljevic, Branislava
    Sekulic, Borivoj
    Agic, Danijela
    El Farra, Amir
    Micanovic, Branimir
    Vejnovic, Tihomir
    Urosevic, Ivana
    Savic, Aleksandar
    [J]. CLINICAL CASE REPORTS, 2024, 12 (05):
  • [48] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [49] Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience
    de Guibert, Sophie
    de Latour, Regis Peffault
    Varoqueaux, Nathalie
    Labussiere, Helene
    Rio, Bernard
    Jaulmes, Dominique
    Eveillard, Jean-Richard
    Dulucq, Stephanie
    Stoppa, Anne-Marie
    Bouscary, Didier
    Girodon, Francois
    Bonnotte, Bernard
    Laskri, Djamila
    Socie, Gerard
    Lamy, Thierry
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (09): : 1276 - 1283
  • [50] Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria
    Tomita, Akihiro
    Shirasugi, Yukari
    Ito, Takahiko
    Tsurumi, Hisashi
    Naoe, Tomoki
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (07) : 1139 - 1141
12345